Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women.

Menopause (New York, N.Y.)

Volumn 10, Issue 5, 2003, Pages 440-447

  Ylikorkala, Olavi ^a   Cacciatore, Bruno ^a   Halonen, Kaija ^a   Lassila, Riitta ^a   Lammintausta, Risto ^a   Rutanen, Eeva Marja ^a   Heikkinen, Jorma ^a   Komi, Janne ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 (4 CHLORO 1,2 DIPHENYL BUT 1 ENYL)PHENOXY)ETHANOL; 2-(4-(4-CHLORO-1,2-DIPHENYL-BUT-1-ENYL)PHENOXY)ETHANOL; BIOLOGICAL MARKER; DRUG DERIVATIVE; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

AGED; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FIBRINOGEN; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRIGLYCERIDES;

EID: 0642306447     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000063566.84134.98     Document Type: Article

References (0)